Medline Industries <MDLN.O>: Morgan Stanley cuts target price to $48.00 from $52.00
MDLN•Related News
Mira Pharma reports positive 7-day dog toxicokinetic study results for obesity drug candidate SKNY-1
MIRA•
Aligos Q2 FY26 net loss narrows 91% to $1.5 million
ALGS•
NextTrip partners with KC Global Media to expand JOURNY TV across Asia-Pacific, Middle East and Africa
NTRP•
Centrus Energy signs LEU, HALEU enrichment supply deal with X-energy
LEU•
Oncor Q2 net income rises to $428 million from $259 million
SRE•